SCHEMBL23098908

SCHEMBL23098908

c1ccc(-n2c3ccccc3c3cc4[nH]c5c(-c6ccccn6)cccc5c4cc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAPK14 Q16539 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ PDK4 Q16654 1/20 0.35
▸ GRM5 P41594 3/20 0.34
▸ NPY5R Q15761 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ MCL1 Q07820 2/20 0.32
▸ BRD4 O60885 2/20 0.32
▸ LOXL3 P58215 1/20 0.32
▸ LOXL2 Q9Y4K0 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ BRD2 P25440 1/20 0.32
▸ BRD3 Q15059 1/20 0.32
▸ BAZ2B Q9UIF8 1/20 0.32
▸ BAZ2A Q9UIF9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23098923 0.88 NPY5R (0.40) KDM4EATML3MBTL1MAPK14ADORA3
SCHEMBL23098905 0.78 L3MBTL1 (0.47) KDM4EATML3MBTL1
SCHEMBL28418744 0.76 KDM4E (0.50) KDM4EATML3MBTL1MAPK14GRM5
SCHEMBL29783135 0.76 KDM4E (0.50) KDM4EATML3MBTL1MAPK14GRM5
SCHEMBL19636228 0.76 KIF11 (0.49) KDM4EATML3MBTL1
SCHEMBL17524716 0.76 KDM4E (0.47) KDM4EATML3MBTL1MAPK14GRM5
SCHEMBL19636290 0.75 L3MBTL1 (0.50) KDM4EATML3MBTL1
SCHEMBL17486148 0.75 KDM4E (0.49) KDM4EATML3MBTL1MAPK14GRM5
SCHEMBL29402271 0.75 KDM4E (0.56) KDM4EATML3MBTL1
SCHEMBL31652 0.75 KDM4E (0.56) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
EP-3621971-B1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-06-23 — — EP disclosed
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES CYP1B1, ECI1, FIS1 KDM4E 3933/4885ATM 4451/4885L3MBTL1 2498/4885
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices CYP1B1, ECI1, FIS1 KDM4E 3933/4885ATM 4451/4885L3MBTL1 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback